Clinical Data Sanofi immune drug hopeful posts mixed results in mid-stage tests pharminent April 7, 2026
Clinical Data Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3 pharminent April 7, 2026
Clinical Data ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH pharminent April 2, 2026
Clinical Data Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment pharminent April 2, 2026
Clinical Data ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity pharminent April 2, 2026
Clinical Data Viridian reports positive results from elegrobart phase 3 trial pharminent April 1, 2026
Clinical Data ACC 2026: dulaglutide promotes coronary plaque stabilisation in patients with T2D pharminent April 1, 2026
Clinical Data ACC 2026: Sotatercept shows signal in CpcPH-HFpEF at lower dose pharminent April 1, 2026
Clinical Data ACC 2026: Tonlamarsen lowers angiotensinogen without extra BP benefit pharminent April 1, 2026
Clinical Data PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease pharminent March 31, 2026
Clinical Data Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout pharminent March 30, 2026
Clinical Data Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline pharminent March 30, 2026
Clinical Data Wave crashes on obesity drug update; Kodiak’s reboot pays dividends pharminent March 26, 2026
Clinical Data Karyopharm myeloma drug yields mixed data in myelofibrosis trial pharminent March 24, 2026
